The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial.
 
Peter S Hall
Consulting or Advisory Role - Eisai (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Daniel Swinson
Travel, Accommodations, Expenses - Merck
 
Justin S. Waters
No Relationships to Disclose
 
Jonathan Wadsley
Honoraria - Eisai; Genzyme
Speakers' Bureau - Eisai; Genzyme
Research Funding - AstraZeneca; Genzyme
Travel, Accommodations, Expenses - Celgene; Genzyme; Imaging Equipment Limited; Ipsen
 
Stephen Falk
Speakers' Bureau - Merck Serono; Merck Serono; Merck Serono
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Celgene
 
Rajarshi Roy
No Relationships to Disclose
 
Tania Tillett
No Relationships to Disclose
 
Jonathan Nicoll
No Relationships to Disclose
 
Sebastian Cummings
No Relationships to Disclose
 
Simon Aird Grumett
No Relationships to Disclose
 
Konstantinos Kamposioras
No Relationships to Disclose
 
Angel Garcia
No Relationships to Disclose
 
Christine Allmark
No Relationships to Disclose
 
Helen Marshall
No Relationships to Disclose
 
Sharon Ruddock
No Relationships to Disclose
 
Eszter Katona
No Relationships to Disclose
 
Galina Velikova
No Relationships to Disclose
 
Russell D. Petty
No Relationships to Disclose
 
Heike I. Grabsch
No Relationships to Disclose
 
Matthew T. Seymour
Research Funding - Amgen (Inst)